Cardinal Health gains on CVS distribution deal extension
CAH•Cardinal Health entered a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032. Cardinal reaffirmed its fiscal 2027 adjusted EPS growth forecast of 13%-15%, or $12.40-$12.60 per share, and its long-term target of 12%-14%.
1. Distribution agreement extended
Cardinal Health entered a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032, maintaining Cardinal’s existing distribution services for CVS.
2. Outlook reaffirmed
Cardinal reaffirmed its fiscal 2027 adjusted EPS growth forecast of 13%-15%, with adjusted EPS of $12.40-$12.60 per share. It also reaffirmed its long-term adjusted EPS growth target of 12%-14%.
